Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Using human monocytic cell line THP-1, we developed a simple and high-throughput method to evaluate drug allergenicity in vitro, which is utilizing real-time RT-PCR. In addition, we established the cell lines, from THP-1, stably expressing a representative drug metabolizing enzyme CYP3A4, which is expected to be utilized for our new method above mentioned.
|